Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
The company is confident of addressing the concern raised by the USFDA
Sen spent a decade with Biocon and held various key roles,
The drug will target specific genetic mutations prevalent in certain types of cancers
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Chlorpromazine Hydrochloride Injection is used to treat certain mental/mood disorders
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
Subscribe To Our Newsletter & Stay Updated
